Douglas Carlson
To Collegium Pharmaceutical next, and Douglas Carlson has been appointed Vice President of Business Development.
Carlson comes from BTG International where he held the role of Senior Director, Business Development and prior to this he served at Ovation Pharmaceuticals playing a role in the sale of Ovation to Lundbeck.
Michael Heffernan , CEO of Collegium, expressed his pleasure in the appointment: “As we rapidly advance Oxycodone DETERx® towards an NDA filing within the next 12 months, we will be initiating a process to identify potential commercial partners for both the U.S. and international markets. We are excited to have a person with Doug's experience and background joining the team at this important time for the Company.”